Zhengfang Yi

21PUBLICATIONS
43CO-AUTHORS
Cellular immunologyToxicology (incl. clinical toxicology)Molecular targetsPharmacogenomicsBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 10, 2024
A Small-Molecule BCL6 Inhibitor as an Anti-Proliferative Agent for Diffuse Large B-Cell Lymphoma.

Yajing Xing, Weikai Guo, Min Wu

|Apr 01, 2024
Discovery of the Highly Selective and Potent STAT3 Inhibitor for Pancreatic Cancer Treatment.

Huang Chen, Aiwu Bian, Wenbo Zhou

|Dec 06, 2023
Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer.

Haijun Gu, Ting Zhang, Tian Guan

|Nov 14, 2022
Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer.

Huang Chen, Wenbo Zhou, Aiwu Bian

|Oct 25, 2022
Discovery of a Highly Potent and Orally Bioavailable STAT3 Dual Phosphorylation Inhibitor for Pancreatic Cancer Treatment.

Peng He, Aiwu Bian, Ying Miao

|Sep 14, 2022
Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr705/Ser727 Inhibitory Activity for Gastric Cancer Treatment.

Peng He, Ying Miao, Yue Sun

Pageof 4

Frequent Collaborators

10 joint publications

Yihua Chen

9 joint publications

Mingyao Liu

5 joint publications

Peng He

4 joint publications

Huang Chen